Harbour Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Harbour Investments's AMGN Position: Q2 2026 in Review
Harbour Investments reduced its Amgen (AMGN) stake by 4.2% in Q2 2026, selling an estimated $124K and leaving 8,295 shares worth $3M. The position accounts for 0.04% of the portfolio, ranked #413.
Harbour Investments first reported a position in AMGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.05M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Harbour Investments held 8,295 shares of Amgen worth $3M as of Q2 2026.
- Harbour Investments sold 363 Amgen shares in Q2 2026, an estimated $124K.
- Amgen made up 0.04% of Harbour Investments's portfolio in Q2 2026, its #413 holding.
- Harbour Investments first reported a position in Amgen in Q1 2021 and has held it in 21 quarters since.
- Harbour Investments's Amgen position peaked at $3.05M in Q1 2026.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.